Europe — EMA

Paklitaksel Kabi (Paclitaxel)

Paclitaxel, the active ingredient in Paklitaksel Kabi, is an antineoplastic presented as a unknown/unknown for intravenous use. It treats various cancers and is administered in oncology patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paklitaksel Kabi, is an antineoplastic presented as a unknown/unknown for intravenous use. It treats various cancers and is administered in oncology patients. GNH USA supplies Paklitaksel Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres worldwide.

What is Paclitaxel used for?

Paklitaksel Kabi is a taxane‑ ---

What are the side effects of Paclitaxel?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →